Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
Mammalian target of rapamycin (mTOR), a serine/threonine kinase involved in cell proliferation, survival, metabolism and immunity, was reportedly activated in various cancers. However, the clinical role of mTOR in renal cell carcinoma (RCC) is controversial. Here we detected the expression and progn...
Main Authors: | Na Li, Jie Chen, Qiang Liu, Hongyi Qu, Xiaoqing Yang, Peng Gao, Yao Wang, Huayu Gao, Hong Wang, Zuohui Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/11901.pdf |
Similar Items
-
Impact of mTOR signaling pathway on CD8+ T cell immunity through Eomesodermin in response to invasive candidiasis
by: Jiahui Zhang, et al.
Published: (2021-06-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01) -
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
by: Demin Fan, et al.
Published: (2020-06-01) -
Advanced Research of mTOR and Lung Carcinoid Tumors
by: Zixuan ZHANG, et al.
Published: (2013-01-01) -
Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway
by: Yan Gao, et al.
Published: (2019-11-01)